Stay updated on Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe NCT02799901 study page now shows a 403 Forbidden error instead of the study details. The content and navigation are replaced by a generic access-denied screen.SummaryDifference18%

- Check19 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects a deployment/version update rather than a modification to the study information presented.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page no longer lists the MeSH term 'Melanoma' and the 'related topics' section including 'MedlinePlus Genetics', reducing the amount of contextual topic information shown for the study.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page adds Melanoma and MedlinePlus Genetics as related topics and updates the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.2%

- Check40 days agoChange DetectedThe related topics list no longer includes 'Melanoma' and 'MedlinePlus Genetics', altering the disease context and topic navigation for this study.SummaryDifference0.2%

- Check55 days agoChange DetectedMelanoma appears as a new topic on the page and related topics such as MedlinePlus Genetics were added; the page's revision number updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.